Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists

Abstract

Both, surgery- or radiotherapy-based treatment regimens are feasible options in the management of Stage III N2 NSCLC. The different opinions reflected in the results of this manuscript reinforce the importance of a multidisciplinary setting and the importance of shared decision-making with the patient.